Header Logo

Connection

Alan Schneyer to Rats

This is a "connection" page, showing publications Alan Schneyer has written about Rats.
Connection Strength

0.218
  1. Brown ML, Kimura F, Bonomi LM, Ungerleider NA, Schneyer AL. Differential synthesis and action of TGF? superfamily ligands in mouse and rat islets. Islets. 2011 Nov-Dec; 3(6):367-75.
    View in: PubMed
    Score: 0.070
  2. Sidis Y, Tortoriello DV, Holmes WE, Pan Y, Keutmann HT, Schneyer AL. Follistatin-related protein and follistatin differentially neutralize endogenous vs. exogenous activin. Endocrinology. 2002 May; 143(5):1613-24.
    View in: PubMed
    Score: 0.036
  3. Nam J, Perera P, Gordon R, Jeong YH, Blazek AD, Kim DG, Tee BC, Sun Z, Eubank TD, Zhao Y, Lablebecioglu B, Liu S, Litsky A, Weisleder NL, Lee BS, Butterfield T, Schneyer AL, Agarwal S. Follistatin-like 3 is a mediator of exercise-driven bone formation and strengthening. Bone. 2015 Sep; 78:62-70.
    View in: PubMed
    Score: 0.022
  4. Meng C, Guo N, Wei Q, Shi F, Schneyer AL, Xia Y, Mao D. Expression of repulsive guidance molecule b (RGMb) in the uterus and ovary during the estrous cycle in rats. Acta Histochem. 2014 Oct; 116(8):1231-6.
    View in: PubMed
    Score: 0.021
  5. Dasarathy S, McCullough AJ, Muc S, Schneyer A, Bennett CD, Dodig M, Kalhan SC. Sarcopenia associated with portosystemic shunting is reversed by follistatin. J Hepatol. 2011 May; 54(5):915-21.
    View in: PubMed
    Score: 0.016
  6. vom Saal FS, Akingbemi BT, Belcher SM, Crain DA, Crews D, Guidice LC, Hunt PA, Leranth C, Myers JP, Nadal A, Olea N, Padmanabhan V, Rosenfeld CS, Schneyer A, Schoenfelder G, Sonnenschein C, Soto AM, Stahlhut RW, Swan SH, Vandenberg LN, Wang HS, Watson CS, Welshons WV, Zoeller RT. Flawed experimental design reveals the need for guidelines requiring appropriate positive controls in endocrine disruption research. Toxicol Sci. 2010 06; 115(2):612-3.
    View in: PubMed
    Score: 0.016
  7. Babitt JL, Zhang Y, Samad TA, Xia Y, Tang J, Campagna JA, Schneyer AL, Woolf CJ, Lin HY. Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor. J Biol Chem. 2005 Aug 19; 280(33):29820-7.
    View in: PubMed
    Score: 0.011
  8. Sidis Y, Schneyer AL, Keutmann HT. Heparin and activin-binding determinants in follistatin and FSTL3. Endocrinology. 2005 Jan; 146(1):130-6.
    View in: PubMed
    Score: 0.011
  9. Besecke LM, Guendner MJ, Schneyer AL, Bauer-Dantoin AC, Jameson JL, Weiss J. Gonadotropin-releasing hormone regulates follicle-stimulating hormone-beta gene expression through an activin/follistatin autocrine or paracrine loop. Endocrinology. 1996 Sep; 137(9):3667-73.
    View in: PubMed
    Score: 0.006
  10. Wang QF, Khoury RH, Smith PC, McConnell DS, Padmanahban V, Midgley AR, Schneyer AL, Crowley WF, Sluss PM. A two-site monoclonal antibody immunoradiometric assay for human follistatin: secretion by a human ovarian teratocarcinoma-derived cell line (PA-1). J Clin Endocrinol Metab. 1996 Apr; 81(4):1434-41.
    View in: PubMed
    Score: 0.006
  11. Sluss PM, Schneyer AL, Franke MA, Reichert LE. Porcine follicular fluid contains both follicle-stimulating hormone agonist and antagonist activities. Endocrinology. 1987 Apr; 120(4):1477-81.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.